Physician profile
Steven C Kim
NPI 1750331195
$4,918.62
in general payments reported to CMS, 2019-2025
40 companies · $814 in 2025
The $814 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $354 · 2020: $530 · 2021: $643 · 2022: $634 · 2023: $1,089 · 2024: $856 · 2025: $814.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,400 · Education: $359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,399.68 |
| Education | $358.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $905.26 | 2020-2025 | Xtandi |
| Bayer Healthcare Pharmaceuticals INC. | $589.04 | 2019-2025 | |
| Endo Pharmaceuticals INC. | $503.14 | 2019-2023 | Xiaflex, Aveed |
| Boston Scientific Corporation | $375.04 | 2019-2025 | Axonics, Rezum Generator |
| Accord Healthcare, INC. | $304.18 | 2022-2025 | |
| Pfizer INC. | $295.26 | 2019-2025 | |
| Janssen Biotech, INC. | $190.42 | 2021-2025 | Erleada |
| Coloplast Corp | $163.67 | 2020-2025 | |
| Myriad Genetic Laboratories, INC. | $132.82 | 2020-2022 | |
| Myovant Sciences INC. | $130.94 | 2021-2022 | |
| Abbvie INC. | $120.32 | 2019-2025 | |
| Tolmar Pharmaceuticals, INC. | $114.95 | 2019-2021 | |
| Sanara Medtech INC. | $102.48 | 2021 | |
| 180 Medical, INC. | $90.05 | 2021-2025 | Cure Catheter |
| Medtronic, INC. | $89.91 | 2021-2025 | Interstim, Nuro |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.